Electromed Q1 FY2023 revenue up 7% to $10.7M; net income drops to $0.01 EPS

Electromed, Inc.

2022-Q1 EPS reported $0.01 revenue$10,658,000

Net revenue $10.7M, +7% YoY; net income $81K ($0.01 diluted EPS) vs $439K ($0.05) last year.
Operating income $44K vs $538K a year ago; SG&A up 17.7% due to legal fees and annual sales meeting.
Cash $6.0M, down $2.2M from June 30; repurchased $145K of stock in quarter.
Next-generation 510(k) submitted to FDA; limited market release expected in fiscal Q2 if clearance by mid-Dec.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Electromed, Inc. reported the three months ended September 30, 2022 results: revenue $10.7 million, net income $81,000, EPS $0.01 per diluted share.

Period: the three months ended September 30, 2022
Revenue: $10.7 million
Net income: $81,000
EPS: $0.01 per diluted share
Result: reported results

Exact text from the filing

Net revenue was $10.7 million for the three months ended September 30, 2022, a 7% increase from $10.0 million for the three months ended September 30, 2021 ("Q1 FY 2022")

View on SEC.gov

10 earnings releases filed in the last 30 days. Browse all earnings releases →

Electromed, Inc. filing history →

Source: SEC EDGAR

accession 0000897101-22-000946

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.